1. Centers for Disease Control and Prevention. Current depression among adults-United States, 2006 and 2008. MMWR Morb Mortal Wkly Rep 2010;59:1229-1235.
3. Ogawa S, Fujii T, Koga N, Hori H, Teraishi T, Hattori K, et al. Plasma Ltryptophan concentration in major depressive disorder: new data and meta-analysis. J Clin Psychiatry 2014;75:906-915.
4. Carroll BJ. Dexamethasone suppression test in depression. Lancet 1980;2:1249
5. Samad N, Batool F, Haleem DJ. Neurochemical and behavioral effects of 8-OH-DPAT following exposure to restraint stress in rats. Pharmacol Rep 2007;59:173-180.
7. Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R. The new ‘5-HT’ hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:702-721.
8. Lee MD, Tajar A, O’Neill WT, O’Connor BD, Bartfai G, Boonen S, et al. Lower vitamin D levels are associated with depression among community-dwelling European men. J Psychopharmacol 2011;25:1320-1328.
10. Berk M, Sanders KM, Pasco JA, Jacka FN, Williams LJ, Hayles AL, et al. Vitamin D deficiency may play a role in depression. Med Hypotheses 2007;69:1316-1319.
11. Hoane MR. Assessment of cognitive function following magnesium therapy in the traumatically injured brain. Magnes Res 2007;20:229-236.
12. Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses 2006;67:362-370.
13. Sowa-Kucma M, Szewczyk B, Sadlik K, Piekoszewski W, Trela F, Opoka W, et al. Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. J Affect Disord 2013;151:924-931.
14. Markkula N, Suvisaari J, Saarni SI, Pirkola S, Pena S, Saarni S, et al. Prevalence and correlates of major depressive disorder and dysthymia in an eleven-year follow-up-results from the Finnish Health 2011 Survey. J Affect Disord 2011;173:73-80.
15. Roman M, Jitaru P, Barbante C. Selenium biochemistry and its role for human health. Metallomics 2014;6:25-54.
16. Młyniec K, Gaweł M, Doboszewska U, Starowicz G, Pytka K, Davies CL, et al. Essential elements in depression and anxiety. Part II. Pharmacol Rep 2015;67:187-194.
17. Sher L. Depression and suicidal behavior in alcohol abusing adolescents: possible role of selenium deficiency. Minerva Pediatr 2008;60:201-209.
19. Ogawa S, Fujii T, Koga N, Hori H, Teraishi T, Hattori K, et al. Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis. J Clin Psychiatry 2014;75:906-915.
20. Saveanu RV, Nemeroff CB. Etiology of depression: genetic and environmental factors. Psychiatr Clin North Am 2012;35:51-71.
21. Pasco JA, Jacka FN, Williams LJ, Evans-Cleverdon M, Brennan SL, Kotowicz MA, et al. Dietary selenium and major depression: a nested case-control study. Complement Ther Med 2012;20:119-123.
22. Naureen F, Masroor K, Khatoon F, Ayub S, Ahmed MI, Hasnat A, et al. Zinc and tryptophan levels in anorexia nervosa: a co-relational study. Int J Biomed Eng Sci 2014;1:27-33.
25. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281.
26. Lin YT, Liu TY, Yang CY, Yu YL, Chen TC, Day YJ, et al. Chronic activation of NPFFR2 stimulates the stress related depressive behaviors through HPA axis modulation. Psychoneuroendocrinology 2016;7:73-85.
27. Solovyev ND. Importance of selenium and selenoprotein for brain function: from antioxidant protection to neuronal signaling. J Inorg Biochem 2015;153:1-12.
29. Ibarra O, Gili M, Roca M, Vives M, Serrano MJ, Pareja A, et al. The mediterranean diet and micronutrient levels in depressive patients. Nutr Hosp 2014;31:1171-1175.
32. Singewald N, Sinner C, Hetzenauer A, Sartori SB, Murck H. Magnesium-deficient diet alters depression- and anxiety-related behavior in mice-influence of desipramine and Hypericum perforatum extract. Neuropharmacology 2004;47:1189-1197.
33. Widmer J, Henrotte JG, Raffin Y, Bovier P, Hilleret H, Gaillard JM. Relationship between erythrocyte magnesium, plasma electrolytes and cortisol, and intensity of symptoms in major depressed patients. J Affect Disord 1995;34:201-209.
34. Fernstrom JD. Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev 1983;63:484-546.
35. Placidi GP, Oquendo MA, Malone KM, Huang YY, Ellis SP, Mann JJ. Aggressivity, suicide attempts, a relationship to cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry 2001;50:783-791.